The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Treatment of depression: time to consider folic acid and vitamin B12
Abstract
We review the findings in major depression of a low plasma and particularly red cell folate, but also of low vitamin B12 status. Both low folate and low vitamin B12 status have been found in studies of depressive patients, and an association between depression and low levels of the two vitamins is found in studies of the general population. Low plasma or serum folate has also been found in patients with recurrent mood disorders treated by lithium. A link between depression and low folate has similalrly been found in patients with alcoholism. It is interesting to note that Hong Kong and Taiwan populations with traditional Chinese diets (rich in folate), including patients with major depression, have high serum folate concentrations. However, these countries have very low life time rates of major depression. Low folate levels are furthermore linked to a poor response to antidepressants, and treatment with folic acid is shown to improve response to antidepressants. A recent study also suggests that high vitamin B12 status may be associated with better treatment outcome. Folate and vitamin B12 are major determinants of one-carbon metabolism, in which S-adenosylmethionine (SAM) is formed. SAM donates methyl groups that are crucial for neurological function. Increased plasma homocysteine is a functional marker of both folate and vitamin B12 deficiency. Increased homocysteine levels are found in depressive patients. In a large population study from Norway increased plasma homocysteine was associated with increased risk of depression but not anxiety. There is now substantial evidence of a common decrease in serum/red blood cell folate, serum vitamin B12 and an increase in plasma homocysteine in depression. Furthermore, the MTHFR C677T polymorphism that impairs the homocysteine metabolism is shown to be overrepresented among depressive patients, which strengthens the association. On the basis of current data, we suggest that oral doses of both folic acid (800 µg daily) and vitamin B12 (1 mg daily) should be tried to improve treatment outcome in depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“The WHO ranks unipolar depression as the fourth most important cause of mortality and disability (Murray and Lopez, 1997).”
BackgroundCross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302
A Hundred Cases of Suicide: Clinical Aspects
Barraclough, B. M., Bunch, J., Nelson, B., & Sainsbury, P. (1974) · British Journal of Psychiatry · doi:10.1192/bjp.125.4.355 · Cited by 1,283
Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
Collaboration, H. L. T. (1998) · BMJ · doi:10.1136/bmj.316.7135.894 · Cited by 1,084
Facts and recommendations about total homocysteine determinations: an expert opinion
Refsum, H., Smith, A. D., Ueland, P. M., Nexo, E., Clarke, R., McPartlin, J., Johnston, C., Engbaek, F., Schneede, J., McPartlin, C., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.021634 · Cited by 1,056
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 1×
“Most consensus statements suggest continuation of treatment for 4–9 months after recovery and long-term maintenance treatment after three or more episodes (Geddes et al., 2003).”
BackgroundDepression and the Course of Coronary Artery Disease
Glassman, A. H., & Shapiro, P. A. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.4 · Cited by 676
Homocysteine, folate, methylation, and monoamine metabolism in depression
Bottiglieri, T. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.2.228 · Cited by 546
Vitamin B12, Folate, and Homocysteine in Depression: The Rotterdam Study
Tiemeier, H., van Tuijl, H. R., Hofman, A., Meijer, J., Kiliaan, A. J., & Breteler, M. M. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2099 · Cited by 408 · cited 1×
“Subjects with vitamin B12 deficiency were 70% more likely to have severe depressive disorder than subjects without deficiency (Tiemeier et al., 2002).”
BackgroundEnhancement of recovery from psychiatric illness by methylfolate
Godfrey, P. S. A., Toone, B. K., Bottiglien, T., Laundy, M., Reynolds, E. H., Carney, M. W. P., Flynn, T. G., & Chanarin, I. (1990) · The Lancet · doi:10.1016/0140-6736(90)91942-4 · Cited by 389
Bjelland, I., Tell, G. S., Vollset, S. E., Refsum, H., & Ueland, P. M. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.618 · Cited by 345
Suicide prevention — a medical breakthrough?
Isacsson, G. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.102002113.x · Cited by 342
Coppen, A., & Bailey, J. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00153-1 · Cited by 337
Self-citationThe Shatin Community Mental Health Survey in Hong Kong: II. Major Findings
Chen, C.-N. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820140051005 · Cited by 300
Folate, vitamin B12, and homocysteine in major depressive disorder
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.3.426 · Cited by 287 · cited 1×
“Another study showed that therapy resistance to fluoxetine was significantly increased in patients with low serum folate (Fava et al., 1997).”
BackgroundPenninx, B. W. J. H., Guralnik, J. M., Ferrucci, L., Fried, L. P., Allen, R. H., & Stabler, S. P. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.715 · Cited by 285
Role of S-adenosyl-l-methionine in the treatment of depression: a review of the evidence,,,
Mischoulon, D., & Fava, M. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.1158s · Cited by 285
De Bree, A., Verschuren, W. M. M., Kromhout, D., Kluijtmans, L. A. J., & Blom, H. J. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.599 · Cited by 282
Folic acid, ageing, depression, and dementia
Reynolds, E. H. (2002) · BMJ · doi:10.1136/bmj.324.7352.1512 · Cited by 239
Coppen, A., American Psychological Association, & Bailey, J. (2000) · PsycEXTRA Dataset · doi:10.1037/e323122004-002 · Cited by 236
Self-citationEfficacy of ECT: a meta-analysis
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.3.297 · Cited by 223
The neuropsychiatry of megaloblastic anaemia.
Shorvon, S. D., Carney, M. W., Chanarin, I., & Reynolds, E. H. (1980) · BMJ · doi:10.1136/bmj.281.6247.1036 · Cited by 218
Depression and Folate Status in the US Population
Morris, M. S., Fava, M., Jacques, P. F., Selhub, J., & Rosenberg, I. H. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000068692 · Cited by 201
Randomized Trial of Folic Acid Supplementation and Serum Homocysteine Levels
Wald, D. S., Bishop, L., Wald, N. J., Law, M., Hennessy, E., Weir, D., McPartlin, J., & Scott, J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.5.695 · Cited by 200
Recurrence of bipolar disorders and major depression: A life-long perspective
Angst, J., Gamma, A., Sellaro, R., Lavori, P. W., & Zhang, H. (2003) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-003-0437-2 · Cited by 189
Folate Deficiency in Depressive Illness
Reynolds, E. H., Preece, J. M., Bailey, J., & Coppen, A. (1970) · British Journal of Psychiatry · doi:10.1192/s0007125000193250 · Cited by 183
Self-citationFolic acid enhances lithium prophylaxis.
Coppen, A., Chaudhry, S., & Swade, C. (1986) · Journal of Affective Disorders · doi:10.1016/0165-0327(86)90043-1 · Cited by 164
Self-citationFolate for Depressive Disorders: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Taylor, M. J., Carney, S. M., Goodwin, G. M., & Geddes, J. R. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104042630 · Cited by 163
Nutrition and depression: focus on folate
Alpert, J. E., Mischoulon, D., Nierenberg, A. A., & D, M. F. M. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00327-0 · Cited by 148
Methylenetetrahydrofolate reductase variant and schizophrenia/depression
Arinami, T., Yamada, N., Yamakawa‐Kobayashi, K., Hamaguchi, H., & Toru, M. (1997) · American Journal of Medical Genetics · Cited by 141
Folate deficiency, biopterin and monoamine metabolism in depression
Bottiglieri, T., Hyland, Κ., Laundy, M., Godfrey, P. M., Carney, M. W. P., Toone, B., & Reynolds, E. H. (1992) · Psychological Medicine · doi:10.1017/s0033291700038447 · Cited by 136
Red cell folate concentrations in psychiatric patients
Carney, M. W. P., Chary, T. K. N., Laundy, M., Bottiglieri, T., Chanarin, I., Reynolds, E. H., & Toone, B. (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90093-n · Cited by 134
Folinic Acid (Leucovorin) as an Adjunctive Treatment for SSRI-Refractory Depression
Alpert, J. E., Mischoulon, D., Rubenstein, G., Bottonari, K. A., Nierenberg, A. A., & D, M. F. M. (2002) · Annals of Clinical Psychiatry · doi:10.3109/10401230209147396 · Cited by 134
Dietary Folate and Depressive Symptoms Are Associated in Middle-Aged Finnish Men
Tolmunen, T., Hintikka, J., Tanskanen, A. J., Viinamäki, H. T., Voutilainen, S., Rissanen, T., Kaplan, G. A., & Salonen, J. T. (2003) · Journal of Nutrition · doi:10.1093/jn/133.10.3233 · Cited by 130
Treatment of depression--newer pharmacotherapies.
Mulrow, C. D., Williams, J. W., Trivedi, M. H., Chiquette, E., Aguilar, C., Cornell, J. E., Badgett, R. G., Noël, P. H., Lawrence, V. A., Lee, S., et al. (1999) · PubMed Central · Cited by 124
Late-onset depression: genetic, vascular and clinical contributions
Hickie, I. B., Scott, E. M., Naismith, S. L., Ward, P. B., Turner, K. A., Parker, G. B., Mitchell, P. B., & Wilhelm, K. A. (2001) · Psychological Medicine · doi:10.1017/s0033291701004731 · Cited by 122
Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat
Botez, M. I., Young, S. N., Bachevalier, J., & Gauthier, S. G. (1979) · Nature · doi:10.1038/278182a0 · Cited by 114
Depression and tetrahydrobiopterin: the folate connection.
Coppen, A., Swade, C., Jones, S., Armstrong, R., Blair, J., & Leeming, R. (1989) · Journal of Affective Disorders · doi:10.1016/0165-0327(89)90062-1 · Cited by 101
Self-citationEnhancement of recovery from psychiatric illness by methylfolate
Godfrey, P. M., Crellin, R. F., Toone, B., Flynn, T., Carney, M. W. P., Laundy, M., Chanarin, I., Bottiglieri, T., & Reynolds, E. H. (1992) · The British Journal of Psychiatry · doi:10.1192/bjp.161.1.126 · Cited by 99
S-adenosyl-methionine in depression: A comprehensive review of the literature
Papakostas, G. I., Alpert, J. E., & D, M. F. M. (2003) · Current Psychiatry Reports · doi:10.1007/s11920-003-0085-2 · Cited by 99
Botez, M. I., Young, S. N., Bachevalier, J., & Gauthier, S. G. (1982) · Annals of Neurology · doi:10.1002/ana.410120512 · Cited by 98
Serum and red blood cell folate in depression
Abou‐Saleh, M. T., & Coppen, A. J. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb01303.x · Cited by 94
Self-citationHigh vitamin B12 level and good treatment outcome may be associated in major depressive disorder
Hintikka, J., Tolmunen, T., Tanskanen, A. J., & Viinamäki, H. T. (2003) · BMC Psychiatry · doi:10.1186/1471-244x-3-17 · Cited by 93
Lithium Continuation Therapy Following Electroconvulsive Therapy
Coppen, A. J., Abou‐Saleh, M. T., Milln, P. T. S., Bailey, J., Metcalfe, M., Burns, B. H., & Armond, A. D. (1981) · The British Journal of Psychiatry · doi:10.1192/bjp.139.4.284 · Cited by 92
Self-citationFolate for depressive disorders
Taylor, M. J., Carney, S. M., Geddes, J. R., & Goodwin, G. M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003390 · Cited by 90
Gottfries, C. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf03035129 · Cited by 90
Plasma Folate and Affective Morbidity During Long-Term Lithium Therapy
Coppen, A., & Abou-Saleh, M. T. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.141.1.87 · Cited by 89
Self-citationAbou‐Saleh, M. T., & Coppen, A. J. (1986) · Journal of Psychiatric Research · doi:10.1016/0022-3956(86)90009-9 · Cited by 80
Self-citationSerum folic acid and B12 in 272 psychiatric in-patients
Carney, M. W. P., & SHEFFIELD, B. F. (1978) · Psychological Medicine · doi:10.1017/s0033291700006711 · Cited by 77
Alpert, M., Silva, R. R., & Pouget, E. R. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084024.22282.cd · Cited by 72
Antiepileptic Therapy, Folate Deficiency, and Psychiatric Morbidity: A General Practice Survey
Edeh, J., & Toone, B. (1985) · Epilepsia · doi:10.1111/j.1528-1157.1985.tb05676.x · Cited by 68
Nitric oxide and biopterin in depression and stress
van Amsterdam, J., & Opperhuizen, A. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(98)00140-1 · Cited by 66
Rocco, A. D., Rogers, J., Brown, R., Werner, P., & Bottiglieri, T. (2000) · Movement Disorders · doi:10.1002/1531-8257(200011)15:6<1225::aid-mds1025>3.0.co;2-a · Cited by 65
Pancheri, P., Scapicchio, P. L., & Chiaie, R. D. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003085 · Cited by 58
Change in folate status with antidepressant treatment
Wesson, V. A., LEVITT, A. J., & Joffe, R. T. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90058-2 · Cited by 51
A controlled study of folate levels in Chinese inpatients with major depression in Hong Kong
Lee, S., Wing, Y. K., & Fong, S. Y. Y. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00200-0 · Cited by 49
Homocysteine. Related Vitamins and Neuropsychiatric Disorders
Bolander-Gouaille, C., & Bottiglieri, T. (2003) · doi:10.1007/978-2-287-69375-5 · Cited by 30
Self-citationEnhancement of Recovery from Psychiatric Illness by Methylfolate
PROCTER, A. W. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.159.2.271 · Cited by 24
Continuation Therapy with Antidepressants After Electroconvulsive Therapy.
Abou‐Saleh, M. T., & Coppen, A. J. (1988) · PubMed · Cited by 20
Self-citationFolate concentration in Chinese psychiatric outpatients on long-term lithium treatment
Lee, S., Chow, C. C., Shek, C. C., Wing, Y. K., & Chen, C.-N. (1992) · Journal of Affective Disorders · doi:10.1016/0165-0327(92)90111-i · Cited by 15
Impact of suppression of thyroxine on folate status during acute antidepressant therapy
LEVITT, A. J., Wesson, V. A., & Joffe, R. T. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(98)00033-x · Cited by 14
Cited by
New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?
Fardet, A. (2010) · Nutrition Research Reviews · doi:10.1017/s0954422410000041 · Cited by 1,030
Effects of Vitamin B 12 and Folate Deficiency on Brain Development in Children
Black, M. M. (2008) · Food and Nutrition Bulletin · doi:10.1177/15648265080292s117 · Cited by 393
Gilbody, S., Lewis, S., & Lightfoot, T. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj347 · Cited by 357
Singh, M. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00925 · Cited by 337
Chickpea breeding and management
(2007) · CABI eBooks · doi:10.1079/9781845932138.000 · Cited by 309
Metadata
- Authors
- Coppen, A., & Bolander-Gouaille, C.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2005-01
- Volume
- 19
- Issue
- 1
- Pages
- 59-65
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2123593284
- Cited by
- 373
- References
- 61
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.